Open Access
Numéro
OCL
Volume 21, Numéro 3, May-June 2014
Numéro d'article D307
Nombre de pages 4
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
DOI https://doi.org/10.1051/ocl/2013057
Publié en ligne 29 avril 2014
  • Afzal S, Bojesen SE, Nordestgaard BG. 2013. Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimers Dement. DOI: 10.1016/j.jalz.2013. 05.1765. [Google Scholar]
  • Annweiler C, Beauchet O. 2011. Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology 37: 249–258. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Beauchet O. 2012. Possibility of a new anti-alzheimer’s disease pharmaceutical composition combining memantine and vitamin D. Drugs Aging 29: 81–91. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Beauchet O. 2013. Vitamin D and cognition: recommendations for future trials. J. Am. Geriatr. Soc. 61: 1049–1050. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Allali G, Allain P, et al. 2009. Vitamin D and cognitive performance in adults: a systematic review. Eur. J. Neurol. 16: 1083–1089. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Le Gall D, Fantino B, Beauchet O, Tucker KL, Buell JS. 2010. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 75: 95. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Schott AM, Allali G, et al. 2010. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74: 27–32. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Schott AM, Berrut G, Chauviré V, Le Gall D, Inzitari M, Beauchet O. 2010. Vitamin D and ageing: neurological issues. Neuropsychobiology 62: 139–150. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beauchet O. 2010. Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 75: 1810–1816. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Fantino B, Le Gall D, Schott AM, Berrut G, Beauchet O. 2011. Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J. Am. Geriatr. Soc. 59: 169–171. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O. 2011. Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement. Geriatr. Cogn. Disord. 32: 273–278. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. 2011. Vitamin D in the elderly: 5 points to remember. Geriatr. Psychol. Neuropsych. Vieil. 9: 259–267. [Google Scholar]
  • Annweiler C, Fantino B, Gautier J, Beaudenon M, Thiery S, Beauchet O. 2012. Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J. Am. Geriatr. Soc. 60: 793–795. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Herrmann FR, Fantino B, Brugg B, Beauchet O. 2012. Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn. Behav. Neurol. 25: 121–127. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O. 2012. Higher vitamin D dietary intake is associated with lower risk of Alzheimer’s disease: a 7-year follow-up. J. Gerontol. A Biol. Sci. Med. Sci. 67: 1205–1211. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Llewellyn DJ, Beauchet O. 2013. Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J. Alzheimers Dis. 33: 659–674. [PubMed] [Google Scholar]
  • Annweiler C, Montero-Odasso M, Hachinski V, Seshadri S, Bartha R, Beauchet O. 2013. Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol. Nutr. Food Res. 57: 267–276. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. 2013. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J. Alzheimers Dis. 37: 147–171. [PubMed] [Google Scholar]
  • Annweiler C, Brugg B, Peyrin JM, Bartha R, Beauchet O. 2014. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol. Aging 35: 331–335. [CrossRef] [PubMed] [Google Scholar]
  • Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM. 2001. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 21: 98–108. [PubMed] [Google Scholar]
  • Brown J, Bianco JI, McGrath JJ, Eyles DW. 2003. 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 343: 139–143. [CrossRef] [PubMed] [Google Scholar]
  • Buell JS, Dawson-Hughes B, Scott TM, et al. 2010. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74: 18–26. [CrossRef] [PubMed] [Google Scholar]
  • Cavalli A, Bolognesi ML, Minarini A, et al. 2008. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 51: 347–372. [CrossRef] [PubMed] [Google Scholar]
  • Etgen T, Sander D, Bickel H, Sander K, Förstl H. 2012. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement. Geriatr. Cogn. Disord. 33: 297–305. [CrossRef] [PubMed] [Google Scholar]
  • Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. 2002. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13: 100–105. [CrossRef] [PubMed] [Google Scholar]
  • Holick MF. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266–281. [CrossRef] [PubMed] [Google Scholar]
  • Ibi M, Sawada H, Nakanishi M, et al. 2001. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 40: 761–771. [CrossRef] [PubMed] [Google Scholar]
  • Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T. 2011. 1α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide (1–40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 8: 20. [CrossRef] [PubMed] [Google Scholar]
  • Kalueff AV, Tuohimaa P. 2007. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 10: 12–19. [CrossRef] [PubMed] [Google Scholar]
  • Llewellyn DJ, Lang IA, Langa KM, et al. 2010. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 170: 1135–1141. [CrossRef] [PubMed] [Google Scholar]
  • Moore ME, Piazza A, McCartney Y, Lynch MA. 2005. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem. Soc. Trans. 33: 573–577. [CrossRef] [PubMed] [Google Scholar]
  • Masoumi A, Goldenson B, Ghirmai S, et al. 2009. 1Alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J. Alzheimers Dis. 17: 703–717. [PubMed] [Google Scholar]
  • Prybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N. 2008. Rapid correction of low vitamin D status in nursing home residents. Osteoporos. Int. 19: 1621–1628. [CrossRef] [PubMed] [Google Scholar]
  • Slinin Y, Paudel ML, Taylor BC, et al. 2010. Osteoporotic Fractures in Men (MrOS) Study Research Group. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 74: 33–41. [CrossRef] [PubMed] [Google Scholar]
  • Slinin Y, Paudel M, Taylor BC, et al. 2012. Study of Osteoporotic Fractures Research Group. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J. Gerontol. A Biol. Sci. Med. Sci. 67: 1092–1098. [CrossRef] [PubMed] [Google Scholar]
  • Stein MS, Scherer SC, Ladd KS, Harrison LC. 2011. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer’s disease. J. Alzheimers Dis. 26: 477–484. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.